{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:20:44Z","timestamp":1790252444348,"version":"4.1.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12931-017-0584-z","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T06:44:22Z","timestamp":1495176262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides"],"prefix":"10.1186","volume":"18","author":[{"given":"Wilmore C.","family":"Webley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"key":"584_CR1","doi-asserted-by":"crossref","first-page":"375S","DOI":"10.1016\/0091-6749(87)90052-2","volume":"80","author":"B Burrows","year":"1987","unstructured":"Burrows B. The natural history of asthma. J Allergy Clin Immunol. 1987;80:375S\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"584_CR2","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jaci.2010.03.032","volume":"125","author":"DL Hahn","year":"2010","unstructured":"Hahn DL, Starkey MR, Horvat JC, Kim RY, Hansbro PM. Chlamydial infection and asthma: Is early allergic sensitization the only mechanism? J Allergy Clin Immunol. 2010;125:1414\u20135.","journal-title":"J Allergy Clin Immunol"},{"key":"584_CR3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1164\/ajrccm.156.3.9611072","volume":"156","author":"DH Smith","year":"1997","unstructured":"Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic cost of asthma. Am J Resp Crit Care Med. 1997;156:787\u201393.","journal-title":"Am J Resp Crit Care Med"},{"issue":"19","key":"584_CR4","first-page":"150","volume":"2010","author":"P Demoly","year":"2008","unstructured":"Demoly P, Gueron B, Annunziata K, Adamek L, Walters RD. Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev. 2008;2010(19):150\u20137.","journal-title":"Eur Respir Rev"},{"issue":"2","key":"584_CR5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaci.2006.08.042","volume":"119","author":"M Schatz","year":"2007","unstructured":"Schatz M, Zeiger RS, Drane A, Harden K, Cibildak A, Oosterman JE, Kosinski M. Reliability and predictive validity of the Asthma Control Test administered by telephone calls using speech recognition technology. J Allergy Clin Immunol. 2007;119(2):336\u201343.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"584_CR6","first-page":"672","volume":"53","author":"RA McIvor","year":"2007","unstructured":"McIvor RA, Boulet LP, FitzGerald JM, Zimmerman S, Chapman KR. Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician. 2007;53(4):672\u20137.","journal-title":"Can Fam Physician"},{"issue":"10","key":"584_CR7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1164\/rccm.200407-917OC","volume":"171","author":"WC Webley","year":"2005","unstructured":"Webley WC, Salva PS, Andrzejewski C, Cirino F, West CA, Tilahun Y, Stuart ES. The bronchial lavage of pediatric patients with asthma contains infectious Chlamydia. Am J Respir Crit Care Med. 2005;171(10):1083\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"584_CR8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jaci.2005.06.024","volume":"116","author":"RF Lemanske Jr","year":"2005","unstructured":"Lemanske Jr RF, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, Kirk CJ, Reisdorf E, Roberg KA, Anderson EL, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005;116:571\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"584_CR9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.anai.2013.01.022","volume":"110","author":"PR Wood","year":"2013","unstructured":"Wood PR, Hill VL, Burks ML, Peters JI, Singh H, Kannan TR, Vale S, Cagle MP, Principe MF, Baseman JB, et al. Mycoplasma pneumoniae in children with acute and refractory asthma. Ann Allergy Asthma Immunol. 2013;110(5):328\u201334. e321.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"584_CR10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1183\/09031936.06.00074705","volume":"27","author":"DW Denning","year":"2006","unstructured":"Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthmma. Eur Respir J. 2006;27:615\u201326.","journal-title":"Eur Respir J"},{"key":"584_CR11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1183\/09031936.02.00254402","volume":"19","author":"LC Hertzen von","year":"2002","unstructured":"von Hertzen LC. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae. Eur Respir J. 2002;19:546\u201356.","journal-title":"Eur Respir J"},{"key":"584_CR12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/00365540110077155","volume":"34","author":"L Hertzen von","year":"2002","unstructured":"von Hertzen L, Vasankari T, Liippo K, Wahlstr\u00f6m E, Puolakkainen M. Chlamydia pneumoniae and severity of asthma. Scand J Infect Dis. 2002;34:22\u20137.","journal-title":"Scand J Infect Dis"},{"key":"584_CR13","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/j.1365-2222.2005.02391.x","volume":"35","author":"Y Cho","year":"2005","unstructured":"Cho Y, Kim T, Lee T, Moon K, Lee J, Kim Y, Lee K, Moon H. Chlamydia pneumoniae infection enhances cellular proliferation and reduces steroid responsiveness of human peripheral blood mononuclear cells via a tumor necrosis factor-alpha-dependent pathway. Clinical & Experimental Allergy. 2005;35:1625\u201331.","journal-title":"Clinical & Experimental Allergy"},{"key":"584_CR14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/thorax.55.5.424","volume":"55","author":"N Pearce","year":"2000","unstructured":"Pearce N, Douwes J, Beasley R. Is allergen exposure the major primary cause of asthma? Thorax. 2000;55:424\u201331.","journal-title":"Thorax"},{"key":"584_CR15","doi-asserted-by":"crossref","unstructured":"Thomsen SF, van der Sluis S, Kyvik KO, Backer V. A study of asthma severity in adult twins. Clin Respir J. 2011.","DOI":"10.1111\/j.1752-699X.2011.00273.x"},{"key":"584_CR16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bmj.299.6710.1259","volume":"299","author":"DP Strachan","year":"1989","unstructured":"Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299:1259\u201360.","journal-title":"BMJ"},{"issue":"Supplement 1","key":"584_CR17","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1136\/thorax.55.suppl_1.S2","volume":"55","author":"DP Strachan","year":"2000","unstructured":"Strachan DP. Family size, infection and atopy: the first decade of the \"hygiene hypothesis\". Thorax. 2000;55(Supplement 1):S2\u201310.","journal-title":"Thorax"},{"issue":"1","key":"584_CR18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/ACI.0b013e32835ad0d2","volume":"13","author":"C Brooks","year":"2013","unstructured":"Brooks C, Pearce N, Douwes J. The hygiene hypothesis in allergy and asthma: an update. Curr Opin Allergy Clin Immunol. 2013;13(1):70\u20137.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"584_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaci.2014.11.011","volume":"135","author":"YJ Huang","year":"2015","unstructured":"Huang YJ, Boushey HA. The microbiome in asthma. J Allergy Clin Immunol. 2015;135(1):25\u201330.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"584_CR20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1183\/09031936.00071711","volume":"38","author":"WC Webley","year":"2011","unstructured":"Webley WC, Hahn DL. Respiratory Chlamydophyla pneumoniae resides primarily in the lower airway. Eur Respir J. 2011;38(4):994\u20135.","journal-title":"Eur Respir J"},{"key":"584_CR21","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1164\/ajrccm.162.3.9912134","volume":"162","author":"L Wu","year":"2000","unstructured":"Wu L, Skinner SJM, Lambie N, Vuletic JC, Blasi F, Black PN. Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162:1148\u201351.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"584_CR22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008578","volume":"5","author":"M Hilty","year":"2010","unstructured":"Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, et al. Disordered microbial communities in asthmatic airways. PLoS One. 2010;5(1), e8578.","journal-title":"PLoS One"},{"issue":"2","key":"584_CR23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jaci.2010.10.048","volume":"127","author":"YJ Huang","year":"2011","unstructured":"Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, Woyke T, Allgaier M, Bristow J, Wiener-Kronish JP, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol. 2011;127(2):372\u201381. e371-373.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"584_CR24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MCP.0b013e32834daff8","volume":"18","author":"JT Good Jr","year":"2012","unstructured":"Good Jr JT, Rollins DR, Martin RJ. Macrolides in the treatment of asthma. Curr Opin Pulm Med. 2012;18(1):76\u201384.","journal-title":"Curr Opin Pulm Med"},{"issue":"Suppl 1","key":"584_CR25","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1513\/AnnalsATS.201306-187MG","volume":"11","author":"YJ Huang","year":"2014","unstructured":"Huang YJ, Boushey HA. The microbiome and asthma. Ann Am Thorac Soc. 2014;11 Suppl 1:S48\u201351.","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"584_CR26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tim.2015.05.006","volume":"23","author":"WC Webley","year":"2015","unstructured":"Webley WC, Aldridge KL. Infectious asthma triggers: time to revise the hygiene hypothesis? Trends Microbiol. 2015;23(7):389\u201391.","journal-title":"Trends Microbiol"},{"issue":"5","key":"584_CR27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.chom.2015.03.008","volume":"17","author":"SM Teo","year":"2015","unstructured":"Teo SM, Mok D, Pham K, Kusel M, Serralha M, Troy N, Holt BJ, Hales BJ, Walker ML, Hollams E, et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 2015;17(5):704\u201315.","journal-title":"Cell Host Microbe"},{"issue":"21","key":"584_CR28","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/1873-3468.12353","volume":"590","author":"K Shima","year":"2016","unstructured":"Shima K, Coopmeiners J, Graspeuntner S, Dalhoff K, Rupp J. Impact of micro-environmental changes on respiratory tract infections with intracellular bacteria. FEBS Lett. 2016;590(21):3887\u2013904.","journal-title":"FEBS Lett"},{"key":"584_CR29","volume-title":"Bodini A","author":"GL Piacentini","year":"2009","unstructured":"Piacentini GL, Peroni DG, Blasi F, Pescollderungg L, Goller P, Gallmetzer L, Drago L. Bodini A. Atypical bacteria in adenoids and tonsils of children requiring adenotonsillectomy. Acta Oto-laryngologica: Boner AL; 2009."},{"key":"584_CR30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1651-2227.2001.tb00271.x","volume":"90","author":"E Normann","year":"2001","unstructured":"Normann E, Gnarpe J, N\u00e4\u00e4s J, Gnarpe H, Karlsson MG, Wettergren B. Chlamydia pneumoniae in children undergoing adenoidectomy. Acta Pediatr. 2001;90:126\u20139.","journal-title":"Acta Pediatr"},{"issue":"3","key":"584_CR31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pharmthera.2007.11.002","volume":"117","author":"NG Hansbro","year":"2008","unstructured":"Hansbro NG, Horvat JC, Wark PA, Hansbro PM. Understanding the mechanisms of viral induced asthma: new therapeutic directions. Pharmacol Ther. 2008;117(3):313\u201353.","journal-title":"Pharmacol Ther"},{"issue":"6989","key":"584_CR32","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/bmj.310.6989.1225","volume":"310","author":"SL Johnston","year":"1995","unstructured":"Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrrell DA, et al. Community study of role of viral infections in exacerbations of asthma in 9\u201311 year old children. BMJ. 1995;310(6989):1225\u20139.","journal-title":"BMJ"},{"issue":"4","key":"584_CR33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1164\/rccm.200412-1621OC","volume":"172","author":"TV Grissell","year":"2005","unstructured":"Grissell TV, Powell H, Shafren DR, Boyle MJ, Hensley MJ, Jones PD, Whitehead BF, Gibson PG. Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med. 2005;172(4):433\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"584_CR34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1183\/09031936.98.11020345","volume":"11","author":"AF Cunningham","year":"1998","unstructured":"Cunningham AF, Johnston SL, Julious SA, Lampe FC, Ward ME. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Resp J. 1998;11:345\u20139.","journal-title":"Eur Resp J"},{"key":"584_CR35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1081-1206(10)63126-2","volume":"81","author":"DL Hahn","year":"1998","unstructured":"Hahn DL, McDonald R. Can acute Chlamydia pneumoniae infection initiate chronic asthma? Ann Allergy Asthma Immunol. 1998;81:339\u201344.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"584_CR36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1081-1206(10)62760-3","volume":"84","author":"DL Hahn","year":"2000","unstructured":"Hahn DL, Peeling RW, Dillon E, McDonald R, Saikku P. Serologic markers for Chlamydia pneumoniae in asthma. Ann Allergy Asthma Immunol. 2000;84:227\u201333.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"584_CR37","first-page":"431","volume":"39","author":"DL Hahn","year":"1994","unstructured":"Hahn DL. Acute asthmatic bronchitis: A new twist to an old problem. J Fam Pract. 1994;39:431\u20135.","journal-title":"J Fam Pract"},{"key":"584_CR38","first-page":"153","volume":"41","author":"DL Hahn","year":"1995","unstructured":"Hahn DL. Infectious asthma: a reemerging clinical entity? J Fam Pract. 1995;41:153\u20137.","journal-title":"J Fam Pract"},{"issue":"12","key":"584_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027912","volume":"6","author":"A Rantala","year":"2011","unstructured":"Rantala A, Jaakkola JJ, Jaakkola MS. Respiratory infections precede adult-onset asthma. PLoS One. 2011;6(12), e27912.","journal-title":"PLoS One"},{"key":"584_CR40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jama.1991.03470020051031","volume":"266","author":"DL Hahn","year":"1991","unstructured":"Hahn DL, Dodge R, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma. JAMA. 1991;266:225\u201330.","journal-title":"JAMA"},{"key":"584_CR41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1081-1206(10)62666-X","volume":"83","author":"DL Hahn","year":"1999","unstructured":"Hahn DL. Chlamydia pneumoniae, asthma and COPD: what is the evidence? Ann Allergy Asthma Immunol. 1999;83:271\u201392.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"584_CR42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/thx.53.4.254","volume":"53","author":"PJ Cook","year":"1998","unstructured":"Cook PJ, Davies P, Tunnicliffe W, Ayres JG, Honeybourne D, Wise R. Chlamydia pneumoniae and asthma. Thorax. 1998;53:254\u20139.","journal-title":"Thorax"},{"issue":"4","key":"584_CR43","doi-asserted-by":"publisher","first-page":"e35945","DOI":"10.31371\/journal.pone.0035945","volume":"7","author":"DL Hahn","year":"2012","unstructured":"Hahn DL, Schure A, Patel K, Childs T, Drizik E, Webley W. Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. PLoS One. 2012;7(4):e35945. doi: 10.31371\/journal.pone.0035945 .","journal-title":"PLoS One"},{"issue":"4","key":"584_CR44","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3122\/jabfm.2012.04.110309","volume":"25","author":"DL Hahn","year":"2012","unstructured":"Hahn DL, Grasmick M, Hetzel S, Yale S. Azithromycin for bronchial asthma in adults: an effectiveness trial. J Am Board Fam Med. 2012;25(4):442\u201359.","journal-title":"J Am Board Fam Med"},{"key":"584_CR45","first-page":"239","volume-title":"Chlamydia pneumoniae Infection and Disease","author":"DL Hahn","year":"2004","unstructured":"Hahn DL. Role of Chlamydia pneumoniae as an inducer of asthma. In: Friedman H, Yamamoto Y, Bendinelli M, editors. Chlamydia pneumoniae Infection and Disease. New York: Kluwer Academic\/Plenum Publishers; 2004. p. 239\u201362."},{"key":"584_CR46","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1183\/09031936.04.00039004","volume":"24","author":"NC Thomson","year":"2004","unstructured":"Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J. 2004;24:822\u201333.","journal-title":"Eur Respir J"},{"key":"584_CR47","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/infdis\/171.5.1274","volume":"171","author":"Y Shemer-Avni","year":"1995","unstructured":"Shemer-Avni Y, Lieberman D. Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells. J Infect Dis. 1995;171:1274\u20138.","journal-title":"J Infect Dis"},{"key":"584_CR48","first-page":"645","volume-title":"Respiratory Infections in Allergy and Asthma","author":"DL Hahn","year":"2003","unstructured":"Hahn DL. Chlamydia\/Mycoplasma: Do they cause new-onset asthma in adults? In: Johnston SL, Papadopoulos NG, editors. Respiratory Infections in Allergy and Asthma, vol. 178. New York: Marcel Dekker, Inc; 2003. p. 645\u201362."},{"issue":"1","key":"584_CR49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1465-9921-13-32","volume":"13","author":"KK Patel","year":"2012","unstructured":"Patel KK, Anderson EA, Salva PS, Webley WC. The prevalence and identity of Chlamydia-specific IgE in children with asthma and other chronic respiratory symptoms. Respir Res. 2012;13(1):32.","journal-title":"Respir Res"},{"key":"584_CR50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/infdis\/172.1.265","volume":"172","author":"U Emre","year":"1995","unstructured":"Emre U, Sokolovskaya N, Roblin P, Schacter J, Hammerschlag M. Detection of Chlamydia pneumoniae-IgE in children with reactive airway disease. J Infect Dis. 1995;172:265\u20137.","journal-title":"J Infect Dis"},{"issue":"11","key":"584_CR51","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.4049\/jimmunol.156.11.4338","volume":"156","author":"X Yang","year":"1996","unstructured":"Yang X, HayGlass KT, Brunham RC. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol. 1996;156(11):4338\u201344.","journal-title":"J Immunol"},{"issue":"2","key":"584_CR52","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.4049\/jimmunol.162.2.1010","volume":"162","author":"X Yang","year":"1999","unstructured":"Yang X, Gartner J, Zhu L, Wang S, Brunham RC. IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J Immunol. 1999;162(2):1010\u20137.","journal-title":"J Immunol"},{"issue":"11","key":"584_CR53","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/IAI.66.11.5113-5118.1998","volume":"66","author":"JM Penttila","year":"1998","unstructured":"Penttila JM, Anttila M, Puolakkainen M, Laurila A, Varkila K, Sarvas M, Makela PH, Rautonen N. Local immune responses to Chlamydia pneumoniae in the lungs of BALB\/c mice during primary infection and reinfection. Infect Immun. 1998;66(11):5113\u20138.","journal-title":"Infect Immun"},{"issue":"1","key":"584_CR54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0966-842X(02)00011-2","volume":"11","author":"RS Stephens","year":"2003","unstructured":"Stephens RS. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol. 2003;11(1):44\u201351.","journal-title":"Trends Microbiol"},{"issue":"10","key":"584_CR55","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.4049\/jimmunol.160.10.4730","volume":"160","author":"SL Prescott","year":"1998","unstructured":"Prescott SL, Macaubas C, Holt BJ, Smallacombe TB, Loh R, Sly PD, Holt PG. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol. 1998;160(10):4730\u20137.","journal-title":"J Immunol"},{"issue":"3","key":"584_CR56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pharmthera.2003.10.007","volume":"101","author":"PM Hansbro","year":"2004","unstructured":"Hansbro PM, Beagley KW, Horvat JC, Gibson PG. Role of atypical bacterial infection of the lung in predisposition\/protection of asthma. Pharmacol Ther. 2004;101(3):193\u2013210.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"584_CR57","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1164\/rccm.200607-1005OC","volume":"176","author":"JC Horvat","year":"2007","unstructured":"Horvat JC, Beagley KW, Wade MA, Preston JA, Hansbro NG, Hickey DK, Kaiko GE, Gibson PG, Foster PS, Hansbro PM. Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Respir Crit Care Med. 2007;176(6):556\u201364.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"584_CR58","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaci.2009.10.018","volume":"125","author":"JC Horvat","year":"2010","unstructured":"Horvat JC, Starkey MR, Kim RY, Phipps S, Gibson PG, Beagley KW, Foster PS, Hansbro PM. Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J Allergy Clin Immunol. 2010;125(3):617\u201325. 625 e611-625 e616.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"584_CR59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083453","volume":"8","author":"KK Patel","year":"2013","unstructured":"Patel KK, Webley WC. Evidence of infectious asthma phenotype: Chlamydia-induced allergy and pathogen-specific IgE in a neonatal mouse model. PLoS One. 2013;8(12), e83453.","journal-title":"PLoS One"},{"issue":"8","key":"584_CR60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042588","volume":"7","author":"MR Starkey","year":"2012","unstructured":"Starkey MR, Kim RY, Beckett EL, Schilter HC, Shim D, Essilfie AT, Nguyen DH, Beagley KW, Mattes J, Mackay CR, et al. Chlamydia muridarum lung infection in infants alters hematopoietic cells to promote allergic airway disease in mice. PLoS One. 2012;7(8), e42588.","journal-title":"PLoS One"},{"issue":"4","key":"584_CR61","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.4049\/jimmunol.180.4.2225","volume":"180","author":"GE Kaiko","year":"2008","unstructured":"Kaiko GE, Phipps S, Hickey DK, Lam CE, Hansbro PM, Foster PS, Beagley KW. Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity. J Immunol. 2008;180(4):2225\u201332.","journal-title":"J Immunol"},{"key":"584_CR62","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2008.06.038","volume":"122","author":"NWJ Schr\u00f6der","year":"2008","unstructured":"Schr\u00f6der NWJ, Crother TM, Naiki Y, Chen S, Wong MH, Yilmaz A, Slepenkin A, Schulte D, Alsabeh R, Doherty TM, et al. Innate immune responses during respiratory tract infection with a bacterial pathogen induce allergic airway sensitization. J Allergy Clin Immunol. 2008;122:595\u2013602.","journal-title":"J Allergy Clin Immunol"},{"key":"584_CR63","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1874306401509010070","volume":"9","author":"LF Keglowich","year":"2015","unstructured":"Keglowich LF, Borger P. The three A's in asthma - airway smooth muscle, airway remodeling & angiogenesis. Open Respir Med J. 2015;9:70\u201380.","journal-title":"Open Respir Med J"},{"key":"584_CR64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fcimb.2014.00034","volume":"4","author":"LA Campbell","year":"2014","unstructured":"Campbell LA, Rosenfeld ME. Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials. Front Cell Infect Microbiol. 2014;4:34.","journal-title":"Front Cell Infect Microbiol"},{"issue":"Pt 5","key":"584_CR65","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1099\/jmm.0.036624-0","volume":"61","author":"CS Park","year":"2012","unstructured":"Park CS, Lee YS, Kwon HS, Lee T, Kim TB, Moon KA, Yoo B, Moon HB, Cho YS. Chlamydophila pneumoniae inhibits corticosteroid-induced suppression of metalloproteinase-9 and tissue inhibitor metalloproteinase-1 secretion by human peripheral blood mononuclear cells. J Med Microbiol. 2012;61(Pt 5):705\u201311.","journal-title":"J Med Microbiol"},{"issue":"6","key":"584_CR66","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1164\/rccm.201109-1640OC","volume":"185","author":"KW McGrath","year":"2012","unstructured":"McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, Fahy JV. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med. 2012;185(6):612\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"584_CR67","doi-asserted-by":"crossref","first-page":"S496","DOI":"10.1016\/S0002-8703(99)70284-X","volume":"138","author":"K C-c","year":"1999","unstructured":"C-c K. Pathologic manifestations of chlamydial infection. Am Heart J. 1999;138:S496\u20139.","journal-title":"Am Heart J"},{"key":"584_CR68","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJM198902023200502","volume":"320","author":"B Burrows","year":"1989","unstructured":"Burrows B, Martinez F, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. New Engl J Med. 1989;320:271\u20137.","journal-title":"New Engl J Med"},{"key":"584_CR69","volume-title":"A Cure for Asthma? What Your Doctor Isn't Telling You, and Why","author":"DL Hahn","year":"2013","unstructured":"Hahn DL. A Cure for Asthma? What Your Doctor Isn't Telling You, and Why. Durham, North Carolina: Peoples Pharmacy Press; 2013."},{"key":"584_CR70","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/thorax.57.7.643","volume":"57","author":"J Douwes","year":"2002","unstructured":"Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57:643\u20138.","journal-title":"Thorax"},{"key":"584_CR71","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","volume":"177","author":"JL Simpson","year":"2008","unstructured":"Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med. 2008;177:148\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"584_CR72","series-title":"US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute","first-page":"417","volume-title":"Guidelines for the diagnosis and management of asthma","author":"Expert Panel Report 3","year":"2007","unstructured":"Expert Panel Report 3. Guidelines for the diagnosis and management of asthma, US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute. 2007. p. 417."},{"key":"584_CR73","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2006.11.639","volume":"119","author":"WC Moore","year":"2007","unstructured":"Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol. 2007;119:405\u201313.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"584_CR74","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jaip.2015.06.016","volume":"3","author":"RS Zeiger","year":"2015","unstructured":"Zeiger RS, Schatz M, Chen W, Li Q, Khatry DB, Tran TN. Adherent uncontrolled adult persistent asthma: characteristics and asthma outcomes. J Allergy Clin Immunol Pract. 2015;3(6):986\u201390. e982.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"584_CR75","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaip.2015.10.002","volume":"4","author":"RS Zeiger","year":"2016","unstructured":"Zeiger RS, Schatz M, Li Q, Chen W, Khatry DB, Tran TN. Characteristics and outcomes of HEDIS-defined asthma patients with COPD Diagnostic Coding. J Allergy Clin Immunol Pract. 2016;4(2):273\u201383. e275.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"584_CR76","doi-asserted-by":"crossref","first-page":"387","DOI":"10.18433\/J37S36","volume":"14","author":"HL Banh","year":"2011","unstructured":"Banh HL. Unconventional treatment options in severe asthma: an overivew. J Pharm Pharm Sci. 2011;14(3):387\u201399.","journal-title":"J Pharm Pharm Sci"},{"issue":"8","key":"584_CR77","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/all.12199","volume":"68","author":"J Reiter","year":"2013","unstructured":"Reiter J, Demirel N, Mendy A, Gasana J, Vieira ER, Colin AA, Quizon A, Forno E. Macrolides for the long-term management of asthma - a meta-analysis of randomized clinical trials. Allergy. 2013;68(8):1040\u20139.","journal-title":"Allergy"},{"key":"584_CR78","doi-asserted-by":"publisher","unstructured":"Kew K, Undela K, Kotorts iI, Ferrara G. Macrolides for chronic asthma. Cochrane Database Syst Rev. 2015; (9): Art. No:CD002997. doi: 10.1002\/14651858.CD002997.pub4 .","DOI":"10.1002\/14651858.CD002997.pub4"},{"issue":"2","key":"584_CR79","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, et al. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343\u201373.","journal-title":"Eur Respir J"},{"key":"584_CR80","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1370\/afm.995","volume":"7","author":"DL Hahn","year":"2009","unstructured":"Hahn DL. Importance of evidence grading for guideline implementation: the example of asthma. Ann Fam Med. 2009;7:364\u20139.","journal-title":"Ann Fam Med"},{"key":"584_CR81","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/thx.2006.066837","volume":"62","author":"J Travers","year":"2007","unstructured":"Travers J, Marsh S, Williams M, Weatherall M, Caldwell B, Shirtcliffe P, Aldington S, Beasley R. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax. 2007;62:219\u201323.","journal-title":"Thorax"},{"key":"584_CR82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.rmed.2004.03.026","volume":"99","author":"K Herland","year":"2005","unstructured":"Herland K, Akselsen J-P, Skj\u00f8nsberg OH, Bjermer L. How representative are clinical study patients with asthma or COPD for a larger \"real life\" population of patients with obstructive lung disease? Respir Med. 2005;99:11\u20139.","journal-title":"Respir Med"},{"issue":"11","key":"584_CR83","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/jamainternmed.2016.5664","volume":"176","author":"SL Johnston","year":"2016","unstructured":"Johnston SL, Szigeti M, Cross M, Brightling C, Chaudhuri R, Harrison T, Mansur A, Robison L, Sattar Z, Jackson D, et al. Azithromycin for acute exacerbations of asthma: The AZALEA randomized clinical trial. JAMA Intern Med. 2016;176(11):1630\u20137.","journal-title":"JAMA Intern Med"},{"issue":"11","key":"584_CR84","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jamainternmed.2016.6046","volume":"176","author":"GG Brusselle","year":"2016","unstructured":"Brusselle GG, Van Braeckel E. AZALEA trial highlights antibiotic overuse in acute asthma attacks. JAMA Intern Med. 2016;176(11):1637\u20138.","journal-title":"JAMA Intern Med"},{"key":"584_CR85","unstructured":"Hahn DL. An unanticipated effect of clinical trial registration. BMJ. 2007. online at http:\/\/www.bmj.com\/rapid-response\/2011\/11\/01\/unanticipated-effect-clinical-trial-registration . Accessed 16 May 2017."},{"issue":"part 2 of 2 par","key":"584_CR86","first-page":"A860","volume":"153","author":"PJ Cook","year":"1996","unstructured":"Cook PJ, Honeybourne D, Miles JF, Ayres JG, Tunnicliffe W, Phipps JM, Treharne JD, Wise R. Chlamydia pneumoniae infection is not associated with unselected cases of acute asthma, but may be associated with chronic type 1 \"brittle\" asthma. Resp Crit Care Med. 1996;153(part 2 of 2 parts):A860. abstract.","journal-title":"Resp Crit Care Med"},{"issue":"2","key":"584_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pctr0010011","volume":"1","author":"DL Hahn","year":"2006","unstructured":"Hahn DL, Plane MB, Mahdi OS, Byrne GI. Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma. PLoS Clin Trials. 2006;1(2), e11. doi: 10.1371\/journal.pctr0010011 .","journal-title":"PLoS Clin Trials"},{"key":"584_CR88","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa043526","volume":"352","author":"JT Grayston","year":"2005","unstructured":"Grayston JT, Kronmal RA, Jackson LA, Parisis AF, Muhlestein JB, Cohen JD, Rogers WJ, Crouse JR, Borrowdale SR, Schron E, et al. Azithromycin for the secondary prevention of coronary events. N Engl J Med. 2005;352:1637\u201345.","journal-title":"N Engl J Med"},{"issue":"11","key":"584_CR89","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/jama.290.11.1459","volume":"290","author":"CM O'Connor","year":"2003","unstructured":"O'Connor CM, Dunne MW, Pfeffer MA, Muhlestein JP, Yao L, Gupta S, Benner RJ, Fisher MR, Cook TD. Azithomycin for the secondary prevention of coronary heart disease events. The WIZARD Study: a randomized controlled trial. JAMA. 2003;290(11):1459\u201366.","journal-title":"JAMA"},{"issue":"8","key":"584_CR90","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","volume":"365","author":"RK Albert","year":"2011","unstructured":"Albert RK, Connett J, Bailey WC, Casaburi R, Cooper Jr JA, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365(8):689\u201398.","journal-title":"N Engl J Med"},{"issue":"20","key":"584_CR91","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","volume":"366","author":"WA Ray","year":"2012","unstructured":"Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366(20):1881\u201390.","journal-title":"N Engl J Med"},{"issue":"18","key":"584_CR92","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1300799","volume":"368","author":"H Svanstrom","year":"2013","unstructured":"Svanstrom H, Pasternak B, Hviid A. Use of azithromycin and death from cardiovascular causes. N Engl J Med. 2013;368(18):1704\u201312.","journal-title":"N Engl J Med"},{"issue":"20","key":"584_CR93","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMc1401831","volume":"370","author":"CM Khosropour","year":"2014","unstructured":"Khosropour CM, Capizzi JD, Schafer SD, Kent JB, Dombrowski JC, Golden MR. Lack of association between azithromycin and death from cardiovascular causes. N Engl J Med. 2014;370(20):1961\u20132.","journal-title":"N Engl J Med"},{"issue":"4","key":"584_CR94","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMct1115170","volume":"367","author":"RP Wenzel","year":"2012","unstructured":"Wenzel RP, Fowler 3rd AA, Edmond MB. Antibiotic prevention of acute exacerbations of COPD. N Engl J Med. 2012;367(4):340\u20137.","journal-title":"N Engl J Med"},{"issue":"1","key":"584_CR95","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/thoraxjnl-2016-208599","volume":"72","author":"LN Segal","year":"2017","unstructured":"Segal LN, Clemente JC, Wu BG, Wikoff WR, Gao Z, Li Y, Ko JP, Rom WN, Blaser MJ, Weiden MD. Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung. Thorax. 2017;72(1):13\u201322.","journal-title":"Thorax"},{"issue":"7","key":"584_CR96","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/thoraxjnl-2013-204517","volume":"69","author":"M Slater","year":"2014","unstructured":"Slater M, Rivett DW, Williams L, Martin M, Harrison T, Sayers I, Bruce KD, Shaw D. The impact of azithromycin therapy on the airway microbiota in asthma. Thorax. 2014;69(7):673\u20134.","journal-title":"Thorax"},{"issue":"3","key":"584_CR97","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2016.03.010","volume":"36","author":"TF Carr","year":"2016","unstructured":"Carr TF, Kraft M. Chronic infection and severe asthma. Immunol Allergy Clin North Am. 2016;36(3):483\u2013502.","journal-title":"Immunol Allergy Clin North Am"},{"key":"584_CR98","doi-asserted-by":"crossref","first-page":"h2147","DOI":"10.1136\/bmj.h2147","volume":"350","author":"K Loudon","year":"2015","unstructured":"Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ. 2015;350:h2147.","journal-title":"BMJ"},{"issue":"8","key":"584_CR99","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S2213-2600(14)70107-9","volume":"2","author":"EH Wong","year":"2014","unstructured":"Wong EH, Porter JD, Edwards MR, Johnston SL. The role of macrolides in asthma: current evidence and future directions. Lancet Respir Med. 2014;2(8):657\u201370.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"584_CR100","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/ajrccm\/147.4.832","volume":"147","author":"EF Juniper","year":"1993","unstructured":"Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis. 1993;147(4):832\u20138.","journal-title":"Am Rev Respir Dis"},{"key":"584_CR101","volume-title":"Kastelik J","author":"K Suresh Babu","year":"2013","unstructured":"Suresh Babu K. Kastelik J. Role of long term antibiotics in chronic respiratory diseases. Respir Med: Morjaria JB; 2013."},{"issue":"1","key":"584_CR102","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1183\/09031936.00136712","volume":"42","author":"P Spagnolo","year":"2013","unstructured":"Spagnolo P, Fabbri LM, Bush A. Long-term macrolide treatment for chronic respiratory disease. Eur Respir J. 2013;42(1):239\u201351.","journal-title":"Eur Respir J"},{"key":"584_CR103","unstructured":"Krishnan JA. Rofumilast or azithromycin to prevent COPD exacerbations (RELIANCE). http:\/\/www.pcori.org\/research-results\/2016\/roflumilast-or-azithromycin-prevent-copd-exacerbations-reliance . Accessed 16 May 2017."},{"issue":"5","key":"584_CR104","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jaip.2014.06.002","volume":"2","author":"DR Rollins","year":"2014","unstructured":"Rollins DR, Good Jr JT, Martin RJ. The role of atypical infections and macrolide therapy in patients with asthma. J Allergy Clin Immunol Pract. 2014;2(5):511\u20137.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-017-0584-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T16:58:07Z","timestamp":1692809887000},"score":1,"resource":{"primary":{"URL":"http:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-017-0584-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,19]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1186\/s12931-017-0584-z","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,19]]},"article-number":"98"}}